AccuRna
Ms. Hattori has experienced in preclinical drug development at Nippon Roche KK. She subsequently joined Pharmacia KK in 1986 (present: Pfizer Japan Inc.) and she engaged in regulatory affairs and clinical development. She transferred to biotechnology division in 1990 and was responsible for sales and marketing. In 1998 she became President and Representative Director of Amersham Pharmacia Biotech KK (present: GE Healthcare Japan). Following the M&A by GE, she was Vice President, Global marketing in GE healthcare Bioscience, GM in Asia-Pacific. In 2011 she joined Thermo Fisher Scientific KK as Vice President, corporate marketing and CMD division.
Now she is a research complex organizer in Center for Wellbeing Research at Keio University.
Ms. Hattori assumed the post of CEO at AccuRna Inc. in April 2017.
Graduated from the faculty of science, the University of Tokyo
Completed executive course in the Graduate School of Business at Stanford University
This person is not in the org chart
This person is not in any teams
This person is not in any offices
AccuRna
AccuRna is pioneering unique drug delivery system (DDS) for nucleic acid therapeutics, both of short chain and long chain.